Premenstrual Syndrome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064539
  • May 2021
  • Pharmaceuticals
  • 117 Pages
The Premenstrual Syndrome market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Premenstrual Syndrome market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Alva-Amco Pharmacal Cos., Inc, Bayer, Inc., Bristol-Myers Squibb Company, Chattem, Inc. (Sanofi), DEKK-TEC, Inc., GlaxoSmithKline Plc, MetP Pharma AG, Novartis AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Premenstrual Syndrome market along with their effects over the forecast period. Similarly, according to the region Premenstrual Syndrome market research report includes the study of opportunities available in the market situation.

The Premenstrual Syndrome market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Premenstrual Syndrome Market:
The Premenstrual Syndrome market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alva-Amco Pharmacal Cos., Inc, Bayer, Inc., Bristol-Myers Squibb Company, Chattem, Inc. (Sanofi), DEKK-TEC, Inc., GlaxoSmithKline Plc, MetP Pharma AG, Novartis AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB

Premenstrual Syndrome Market Segmentation Analysis:
by : Treatment Type
Painkillers
Oral contraceptive pills
Estrogen-only patches and implants
Gonadotropin-releasing hormone
GnRH analogues
Selective serotonin reuptake inhibitors
SSRIs

Global Premenstrual Syndrome Market Segmentation by Regions:
In regional analysis, Premenstrual Syndrome market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Premenstrual Syndrome market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Premenstrual Syndrome Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Premenstrual Syndrome Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Premenstrual Syndrome Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Premenstrual Syndrome Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Premenstrual Syndrome Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Premenstrual Syndrome market, according to the key region.
  • To study the Premenstrual Syndrome market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Premenstrual Syndrome market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Premenstrual Syndrome research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Premenstrual Syndrome market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Premenstrual Syndrome market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Premenstrual Syndrome market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Premenstrual Syndrome market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Premenstrual Syndrome market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Alva-Amco Pharmacal Cos., Inc
  • Bayer, Inc.
  • Bristol-Myers Squibb Company
  • Chattem, Inc. (Sanofi)
  • DEKK-TEC, Inc.
  • GlaxoSmithKline Plc
  • MetP Pharma AG
  • Novartis AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB
  • Painkillers
  • Oral contraceptive pills
  • Estrogen-only patches and implants
  • Gonadotropin-releasing hormone
  • GnRH
  • Painkillers
  • Oral contraceptive pills
  • Estrogen-only patches and implants
  • Gonadotropin-releasing hormone
  • GnRH analogues
  • Selective serotonin reuptake inhibitors
  • SSRIs

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Premenstrual Syndrome Market Snapshot
          2.1.1. Global Premenstrual Syndrome Market By : Treatment Type,2019
               2.1.1.1.Painkillers
               2.1.1.2.Oral contraceptive pills
               2.1.1.3.Estrogen-only patches and implants
               2.1.1.4.Gonadotropin-releasing hormone
               2.1.1.5.GnRH
          2.1.2. Global Premenstrual Syndrome Market By : Treatment Type,2019
               2.1.2.1.Painkillers
               2.1.2.2.Oral contraceptive pills
               2.1.2.3.Estrogen-only patches and implants
               2.1.2.4.Gonadotropin-releasing hormone
               2.1.2.5.GnRH analogues
               2.1.2.6.Selective serotonin reuptake inhibitors
               2.1.2.7.SSRIs
          2.1.3. Global Premenstrual Syndrome Market By End-use,2019
          2.1.4. Global Premenstrual Syndrome Market By Geography,2019

3. Global Premenstrual Syndrome Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By : Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By : Treatment Type, 2020
     4.2. Global Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028

5. Global Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By : Treatment Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By : Treatment Type, 2020
     5.2. Global Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028

6. Global Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028

7. Global Premenstrual Syndrome Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Premenstrual Syndrome Market Analysis, 2018 – 2028 
          7.2.1. North America Premenstrual Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.2.3. North America Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.2.4. North America Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Premenstrual Syndrome Market Analysis, 2018 – 2028 
          7.3.1.  Europe Premenstrual Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.3.3. Europe Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.3.4. Europe Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Premenstrual Syndrome Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Premenstrual Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.4.4. Asia Pacific Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Premenstrual Syndrome Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Premenstrual Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.5.3. Latin America Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.5.4. Latin America Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Premenstrual Syndrome Market Analysis, 2018 – 2028 
          7.6.1.  MEA Premenstrual Syndrome Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.6.3. MEA Premenstrual Syndrome Market Size (US$), By : Treatment Type, 2018 – 2028
          7.6.4. MEA Premenstrual Syndrome Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Premenstrual Syndrome Providers
        8.4.1 Alva-Amco Pharmacal Cos., Inc
                8.4.1.1 Business Description
                8.4.1.2 Alva-Amco Pharmacal Cos., Inc Geographic Operations
                8.4.1.3 Alva-Amco Pharmacal Cos., Inc Financial Information
                8.4.1.4 Alva-Amco Pharmacal Cos., Inc Product Positions/Portfolio
                8.4.1.5 Alva-Amco Pharmacal Cos., Inc Key Developments
        8.4.2 Bayer, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Bayer, Inc. Geographic Operations
                8.4.2.3 Bayer, Inc. Financial Information
                8.4.2.4 Bayer, Inc. Product Positions/Portfolio
                8.4.2.5 Bayer, Inc. Key Developments
        8.4.3 Bristol-Myers Squibb Company
                8.4.3.1 Business Description
                8.4.3.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.3.3 Bristol-Myers Squibb Company Financial Information
                8.4.3.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.3.5 Bristol-Myers Squibb Company Key Developments
        8.4.4 Chattem, Inc. (Sanofi)
                8.4.4.1 Business Description
                8.4.4.2 Chattem, Inc. (Sanofi) Geographic Operations
                8.4.4.3 Chattem, Inc. (Sanofi) Financial Information
                8.4.4.4 Chattem, Inc. (Sanofi) Product Positions/Portfolio
                8.4.4.5 Chattem, Inc. (Sanofi) Key Developments
        8.4.5 DEKK-TEC, Inc.
                8.4.5.1 Business Description
                8.4.5.2 DEKK-TEC, Inc. Geographic Operations
                8.4.5.3 DEKK-TEC, Inc. Financial Information
                8.4.5.4 DEKK-TEC, Inc. Product Positions/Portfolio
                8.4.5.5 DEKK-TEC, Inc. Key Developments
        8.4.6 GlaxoSmithKline Plc
                8.4.6.1 Business Description
                8.4.6.2 GlaxoSmithKline Plc Geographic Operations
                8.4.6.3 GlaxoSmithKline Plc Financial Information
                8.4.6.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.4.6.5 GlaxoSmithKline Plc Key Developments
        8.4.7 MetP Pharma AG
                8.4.7.1 Business Description
                8.4.7.2 MetP Pharma AG Geographic Operations
                8.4.7.3 MetP Pharma AG Financial Information
                8.4.7.4 MetP Pharma AG Product Positions/Portfolio
                8.4.7.5 MetP Pharma AG Key Developments
        8.4.8 Novartis AG
                8.4.8.1 Business Description
                8.4.8.2 Novartis AG Geographic Operations
                8.4.8.3 Novartis AG Financial Information
                8.4.8.4 Novartis AG Product Positions/Portfolio
                8.4.8.5 Novartis AG Key Developments
        8.4.9 Pherin Pharmaceuticals, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Pherin Pharmaceuticals, Inc. Geographic Operations
                8.4.9.3 Pherin Pharmaceuticals, Inc. Financial Information
                8.4.9.4 Pherin Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.9.5 Pherin Pharmaceuticals, Inc. Key Developments
        8.4.10 Umecrine Mood AB
                8.4.10.1 Business Description
                8.4.10.2 Umecrine Mood AB Geographic Operations
                8.4.10.3 Umecrine Mood AB Financial Information
                8.4.10.4 Umecrine Mood AB Product Positions/Portfolio
                8.4.10.5 Umecrine Mood AB Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Premenstrual Syndrome Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Premenstrual Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Premenstrual Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Premenstrual Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Premenstrual Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Premenstrual Syndrome Market Revenue, By : Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Premenstrual Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Premenstrual Syndrome: Market Segmentation 
FIG. 2 Global Premenstrual Syndrome Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Premenstrual Syndrome Market, By : Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Premenstrual Syndrome Market, By : Treatment Type, 2019 (US$ Mn) 
FIG. 6 Global Premenstrual Syndrome Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Premenstrual Syndrome Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Premenstrual Syndrome Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Premenstrual Syndrome Providers, 2019
FIG. 11 Global Premenstrual Syndrome Market Revenue Contribution, By : Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Premenstrual Syndrome Market Revenue Contribution, By : Treatment Type, 2019 & 2028 (Value %) 
FIG. 13 Global Premenstrual Syndrome Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Premenstrual Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Premenstrual Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Premenstrual Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Premenstrual Syndrome Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Premenstrual Syndrome Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Premenstrual Syndrome market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Premenstrual Syndrome Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Premenstrual Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  North America Premenstrual Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  North America Premenstrual Syndrome Market Value, By Country, 2018 – 2028
TABLE  Europe Premenstrual Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Europe Premenstrual Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Europe Premenstrual Syndrome Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Premenstrual Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Premenstrual Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Premenstrual Syndrome Market Value, By Country, 2018 – 2028
TABLE  Latin America Premenstrual Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Premenstrual Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Premenstrual Syndrome Market Value, By Country, 2018 – 2028
TABLE  MEA Premenstrual Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  MEA Premenstrual Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  MEA Premenstrual Syndrome Market Value, By Country, 2018 – 2028
TABLE  Alva-Amco Pharmacal Cos., Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chattem, Inc. (Sanofi): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DEKK-TEC, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MetP Pharma AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pherin Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Umecrine Mood AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Premenstrual Syndrome Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Premenstrual Syndrome Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Premenstrual Syndrome Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Premenstrual Syndrome Market, By Geography, 2019 (US$ Mn)
FIG.  Global Premenstrual Syndrome Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Premenstrual Syndrome Providers, 2016
FIG.  Global Premenstrual Syndrome Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Oral contraceptive pills Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Estrogen-only patches and implants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gonadotropin-releasing hormone Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GnRH Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Premenstrual Syndrome Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Oral contraceptive pills Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Estrogen-only patches and implants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gonadotropin-releasing hormone Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GnRH analogues Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Selective serotonin reuptake inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global SSRIs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Premenstrual Syndrome Market Value, 2018 – 2028, (US$ Mn)